118 related articles for article (PubMed ID: 28426233)
1. Investigation of Classical Organic and Ionic Liquid Cosolvents for Early-Stage Screening in Fragment-Based Inhibitor Design with Unrelated Bacterial and Human Dihydrofolate Reductases.
Toulouse JL; Abraham SMJ; Kadnikova N; Bastien D; Gauchot V; Schmitzer AR; Pelletier JN
Assay Drug Dev Technol; 2017; 15(4):141-153. PubMed ID: 28426233
[TBL] [Abstract][Full Text] [Related]
2. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition.
Park H; Bradrick TD; Howell EE
Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003
[TBL] [Abstract][Full Text] [Related]
3. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
Hicks SN; Smiley RD; Hamilton JB; Howell EE
Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase.
Bastien D; Ebert MC; Forge D; Toulouse J; Kadnikova N; Perron F; Mayence A; Huang TL; Vanden Eynde JJ; Pelletier JN
J Med Chem; 2012 Apr; 55(7):3182-92. PubMed ID: 22424148
[TBL] [Abstract][Full Text] [Related]
5. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
6. Further studies on the role of water in R67 dihydrofolate reductase.
Timson MJ; Duff MR; Dickey G; Saxton AM; Reyes-De-Corcuera JI; Howell EE
Biochemistry; 2013 Mar; 52(12):2118-27. PubMed ID: 23458706
[TBL] [Abstract][Full Text] [Related]
7. Crowders Steal Dihydrofolate Reductase Ligands through Quinary Interactions.
Duff MR; Desai N; Craig MA; Agarwal PK; Howell EE
Biochemistry; 2019 Mar; 58(9):1198-1213. PubMed ID: 30724552
[TBL] [Abstract][Full Text] [Related]
8. Ionic liquid mediated stereoselective synthesis of alanine linked hybrid quinazoline-4(3H)-one derivatives perturbing the malarial reductase activity in folate pathway.
Patel TS; Bhatt JD; Vanparia SF; Patel UH; Dixit RB; Chudasama CJ; Patel BD; Dixit BC
Bioorg Med Chem; 2017 Dec; 25(24):6635-6646. PubMed ID: 29126742
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Competitive Inhibition and Destabilization of Acidothermus cellulolyticus Endoglucanase 1 by Ionic Liquids.
Summers SR; Sprenger KG; Pfaendtner J; Marchant J; Summers MF; Kaar JL
J Phys Chem B; 2017 Dec; 121(48):10793-10803. PubMed ID: 29120187
[TBL] [Abstract][Full Text] [Related]
10. Insight into the cosolvent effect of cellulose dissolution in imidazolium-based ionic liquid systems.
Zhao Y; Liu X; Wang J; Zhang S
J Phys Chem B; 2013 Aug; 117(30):9042-9. PubMed ID: 23829272
[TBL] [Abstract][Full Text] [Related]
11. Characterization and stereochemistry of cofactor oxidation by a type II dihydrofolate reductase.
Brito RM; Reddick R; Bennett GN; Rudolph FB; Rosevear PR
Biochemistry; 1990 Oct; 29(42):9825-31. PubMed ID: 2271620
[TBL] [Abstract][Full Text] [Related]
12. Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.
Srinivasan B; Skolnick J
FEBS J; 2015 May; 282(10):1922-38. PubMed ID: 25703118
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
[TBL] [Abstract][Full Text] [Related]
14. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
[TBL] [Abstract][Full Text] [Related]
15. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases.
Gangjee A; Vasudevan A; Queener SF; Kisliuk RL
J Med Chem; 1996 Mar; 39(7):1438-46. PubMed ID: 8691474
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies of R67 dihydrofolate reductase. Effects of pH and an H62C mutation.
Park H; Zhuang P; Nichols R; Howell EE
J Biol Chem; 1997 Jan; 272(4):2252-8. PubMed ID: 8999931
[TBL] [Abstract][Full Text] [Related]
18. Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein.
Bradrick TD; Beechem JM; Howell EE
Biochemistry; 1996 Sep; 35(35):11414-24. PubMed ID: 8784197
[TBL] [Abstract][Full Text] [Related]
19. Searching sequence space: two different approaches to dihydrofolate reductase catalysis.
Howell EE
Chembiochem; 2005 Apr; 6(4):590-600. PubMed ID: 15812782
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs.
Li R; Sirawaraporn R; Chitnumsub P; Sirawaraporn W; Wooden J; Athappilly F; Turley S; Hol WG
J Mol Biol; 2000 Jan; 295(2):307-23. PubMed ID: 10623528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
